Authored by Dr. Bradley Mouroux

Peripheral neuropathy in Campbell CA is a condition where the nerves outside the brain and spinal cord get damaged. This damage can cause numbness, tingling, burning feelings, weakness, and problems with balance (Joshua, 2022).

In the United States, it is very common. About 1 in 10 adults between ages 40–69 have it. The number goes up with age — about 1 in 4 people aged 70 and older, and about 1 in 3 to almost 1 in 2 people aged 80 and above (Hicks et al., 2021). Overall, about 13.5% of adults aged 40 and older are affected (Hicks et al., 2021). Around the world, it is less common, with about 2.4% of all people having nerve problems, though older adults are more likely to get it (Hämmi, 2022). Neuropathic pain affects 7% to 10% of people in the general population, but it is much higher in people with diabetes — between 20% and 30% (Baskozos et al., 2023).

Nerve disorders like polyneuropathy (when many nerves are affected) make up about 10% of all neurology visits worldwide each year (Elafros et al., 2022; Foundation for Peripheral Neuropathy, 2025). In the U.S., the cost of treating diabetic neuropathy alone is nearly $11 billion every year (Foundation for Peripheral Neuropathy, 2025).

Current medications, such as gabapentin, pregabalin, and duloxetine, mainly help with symptoms, not nerve repair. They can also cause side effects like dizziness, stomach upset, or feeling very tired, which makes some patients stop using them. Because of this, safer options are needed.

Research shows that non-drug approaches can help. These include therapies like red light therapy, shockwave therapy, electrical stimulation, vibration therapy, supplements, and chiropractic care. These treatments aim to help nerves heal, improve blood flow, and restore function.

Clinical studies show real benefits. For example, infrared light therapy improved pain and feeling in up to 66% of patients. Shockwave therapy helped nerves work better and lowered pain after 12 weeks of treatment. Electrical stimulation therapies such as TENS and PEMF also reduce pain. A large review of TENS showed strong pain relief compared to fake (sham) treatments (Johnson et al., 2022). PEMF therapy has also shown promise, with one study reporting a 41.6% drop in pain among cancer patients.

Because neuropathy is becoming more common, costs are rising, and medicines don’t fully solve the problem, both patients and doctors are turning to these safer, evidence-based approaches. These combined strategies use proven therapies like TENS and PEMF along with new methods to give patients better long-term results and quality of life (Wang et al., 2024).

---

Understanding Peripheral Neuropathy: Causes and Symptoms in Campbell CA

Peripheral neuropathy happens when the nerves outside the brain and spinal cord are damaged. This can be caused by problems with metabolism (like high blood sugar), poor blood flow, toxins, or the immune system attacking the nerves.

When blood sugar stays high for too long, it causes changes inside the nerves. Extra sugar gets turned into a substance called sorbitol, which builds up and stresses the nerve. This also lowers antioxidants and increases “oxidative stress,” which harms the nerve’s energy system (the mitochondria). High sugar also changes proteins in the body and triggers inflammation that makes blood vessels around the nerves weaker. With less blood supply, the nerves get damaged.

Mitochondria (the “power plants” inside cells) don’t work well in neuropathy, which lowers energy (ATP) and produces harmful molecules called free radicals. This makes it hard for nerves to repair themselves. At the same time, immune system chemicals (cytokines) call in immune cells that attack the nerves, causing more injury.

Some chemotherapy drugs also hurt nerves but in different ways. For example:

• Taxanes block the system nerves use to move nutrients and signals.
• Platinum drugs damage nerve cell DNA and their energy systems.

These changes affect ion channels (tiny gates on nerves that send electrical signals), leading to abnormal nerve firing, burning pain, and sensitivity.

Neuropathy can affect different types of nerve fibers:

• Small fibers (thin nerves) control pain, temperature, and automatic functions. Damage here causes burning pain, heat/cold sensitivity, and sweating or blood pressure problems.
• Large fibers (thicker nerves) help with balance and movement. Damage here causes numbness, poor balance, and walking problems.

Neuropathy can also come from injuries like compression or trauma, which cause localized nerve damage. In other cases, the cause is unknown (idiopathic), likely from a mix of genes, metabolism, and immune issues.

Doctors stress early detection and treatment. Once too many nerves are lost, disability becomes permanent. The best results come from catching small nerve damage early, fixing the root causes (like blood sugar control), avoiding toxins, and starting therapies that protect or rebuild nerves. This can help preserve nerve function and reduce long-term problems (Laforgia et al., 2021; Li et al., 2024; Saleh & Sedik, 2024).

---

Infrared and Red Light Therapy for Neuropathy: Evidence and Benefits

Infrared and red light therapy, also known as photobiomodulation or low-level laser therapy, is a non-invasive treatment that uses specific types of light to help nerves heal. When this light reaches the cells, it is absorbed by small structures called mitochondria, which are often described as the “power plants” of the cell. The light increases the amount of energy (ATP) the cell can make, reduces harmful molecules that cause stress and inflammation, and improves blood flow. It also activates growth signals that encourage new blood vessels and nerve repair (Dompe et al., 2020).

Several studies have tested how well this therapy works. In one study of 70 cancer patients with chemotherapy-induced neuropathy, the group that received real light therapy had much better results than the group that received a fake treatment. Their neuropathy scores dropped by about 32% after four weeks and more than 50% after eight weeks (Argenta et al., 2016). A more recent study in 2023 looked at 60 patients with diabetic neuropathy. The treatment used red light at 630 nm and near-infrared light at 810 nm for 15 minutes, three times per week, for a total of 12 sessions. Patients improved on both sensation tests and neuropathy scores, and no side effects were reported (Ebadi et al., 2023).

Reviews that combined results from many different studies also support this therapy. These reviews include between eight and twenty controlled studies, and most of them found that red and near-infrared light therapy improved nerve function and reduced pain. However, the results varied because researchers used different wavelengths, light intensities, and session lengths in their studies (Korada et al., 2022).

Most studies used treatment plans that lasted four to twelve weeks, with sessions of 15 to 30 minutes, three times per week. The devices used in these trials ranged from visible red light (around 630 nm) to near-infrared light (800–900 nm). Across these studies, safety was consistently excellent, with almost no negative effects reported (Ebadi et al., 2023).

For patients, this means that infrared and red light therapy is a safe and reasonable option to consider for neuropathy. The science shows that it can reduce pain and improve nerve function, but the success of the treatment depends on using the correct type of light, the right dose, and the proper number of sessions. Home-use devices are widely available but vary greatly in quality, and there is not yet enough strong evidence to show that they work as well as clinical devices. Until more large, long-term studies are available, the best choice is to receive treatment from a clinic using professional equipment with carefully documented settings (De Oliveira Rosso et al., 2018).

---

Shockwave Therapy for Nerve Regeneration and Pain Relief

Extracorporeal shock wave therapy (ESWT) is a treatment that uses sound waves to stimulate tissue. These sound waves cause small changes in the body that improve healing. They increase blood flow, release growth factors, activate stem cells, and reduce inflammation. Together, these effects support the repair of damaged nerves and lower pain (Guo et al., 2022; Kou et al., 2024).

Research in animals has shown that shockwave therapy can protect nerves from damage caused by diabetes. In these studies, the therapy preserved axons, which are the long parts of nerve cells, and helped restore both movement and sensation (Chen et al., 2015). Human studies also suggest that the treatment is helpful, although results vary. Reviews of clinical trials show that shockwave therapy can lower pain and improve function in people with peripheral nerve and musculoskeletal conditions. One review found that patients receiving shockwave therapy reported an average drop of about 1.5 points on a 0–10 pain scale compared to those who did not receive the therapy (De La Corte-Rodríguez et al., 2023). A more recent analysis focused on neuropathy found improvements in pain, some nerve conduction tests, and reduced swelling of nerves. However, the size of the benefits differed between studies, and most trials only followed patients for a short period of time (Yang et al., 2024).

In practice, the treatment usually involves low to medium energy levels ranging from 0.08 to 0.28 mJ/mm². Each session delivers about 1,500 to 3,000 sound wave pulses, and patients typically receive between one and five sessions. These sessions are spaced out over several days or weeks. Guidelines from the International Society for Medical Shockwave Treatment recommend adjusting the strength and number of sessions to fit the patient’s needs and the type of device being used. Side effects are usually mild and temporary, such as minor bruising, skin spots, or short-lived soreness (International Society for Medical Shockwave Treatment, 2024).

The main benefits seen in studies include reduced pain, improved sensation (such as better detection on monofilament tests in people with diabetes), improved nerve signaling in some cases, and reduced swelling in nerves when measured with ultrasound (“Effect of Extracorporeal Shockwaves on Diabetic Neuropathic Foot,” 2020; Jeong et al., 2023).

At present, shockwave therapy appears to be a promising option for patients with peripheral neuropathy. The treatment has scientific support and has shown meaningful improvements in pain and nerve health in both animal and human studies. However, because the available research is still limited and many studies are small or short-term, more large-scale and long-term trials are needed before ESWT can be considered a standard treatment for neuropathy (Yang et al., 2024; International Society for Medical Shockwave Treatment, 2024).

---

Electrical Nerve Stimulation: TENS, PEMF and H-Wave Devices

Electrical nerve stimulation is a group of treatments that use gentle electrical or magnetic signals to reduce nerve pain and, in some cases, help nerves recover. These treatments work by changing how nerve cells send signals, improving blood flow, and encouraging nerve healing.

One of the most common types is TENS, or transcutaneous electrical nerve stimulation. TENS uses small patches placed on the skin that deliver mild pulses of electricity. These pulses stimulate larger nerve fibers, which can block pain signals from reaching the brain. Research reviews show that TENS can provide short-term pain relief compared to fake treatments. The benefits are usually modest but real, and the treatment is considered safe (Johnson et al., 2022).

Another option is PEMF, or pulsed electromagnetic field therapy. Instead of electricity, this method uses changing magnetic fields to affect the nerves. Studies suggest that PEMF can improve blood flow in small vessels and may help repair damaged small nerve fibers. Recent pilot studies and small clinical trials in people with diabetic neuropathy found improvements in blood flow to the skin and reductions in pain, though the number of patients studied has been small and treatment plans varied (Tassone et al., 2023).

A third approach is the H-Wave device, which uses a special waveform designed to cause gentle, non-fatiguing muscle contractions. This increases circulation, supports lymphatic flow, and reduces chronic pain. Reviews and case reports show good results for pain relief and improved function, but many of the studies are small, industry-funded, or do not follow patients for long periods (Williamson et al., 2021; Blum et al., 2008).

When comparing these treatments, the evidence is still limited. Some studies suggest that TENS and PEMF provide similar short-term pain relief, while H-Wave may be better for long-term improvement in circulation and function. One review that combined many different electrical stimulation studies found an average pain reduction of about 1.6 points on standard pain scales compared to fake treatments. However, the strength of the evidence is weakened by the fact that the devices, treatment schedules, and outcome measures varied widely (Johnson et al., 2022).

In practice, TENS is the most affordable and widely available, and many patients can use it at home with proper instruction. PEMF and H-Wave often require use in a clinic or prescription devices that ensure correct settings. Across all three methods, side effects are rare and usually mild, such as slight skin irritation or temporary discomfort. Because the results depend heavily on the exact treatment settings (waveform, intensity, frequency, and duration), it is important for clinicians to carefully document the treatment plan and base recommendations on high-quality research whenever possible.

Current evidence shows that electrical stimulation is a safe option that can provide meaningful pain relief for many people with neuropathy. Still, larger studies with more standardized methods are needed to better understand which type of stimulation works best and how to design the most effective treatment plans (Wolfe et al., 2024; Vance et al., 2022).

---

Vibration Therapy and Sensory Stimulation

Vibration therapy and sensory stimulation are non-drug treatments that use gentle vibrations to improve how nerves and muscles work. These therapies affect nerve signals by increasing blood flow, stimulating nerve endings, and improving balance and movement. The vibrations can be applied to the whole body, known as whole-body vibration (WBV), or to specific areas such as the feet, called focal or plantar vibration.

Whole-body vibration has been studied in people with diabetic neuropathy. It has been shown to improve pain, balance, and overall quality of life. In one randomized trial, patients who used WBV for several weeks reported less pain and better scores on neuropathy tests (Jamal et al., 2019). Other reviews have also found that WBV can improve walking stability and reduce discomfort (Robinson et al., 2018). Focal vibration, which targets smaller areas such as the soles of the feet, has also shown benefits. Studies report that it improves sensation in the feet, reduces pain, and helps patients feel steadier when walking (Sabziparvar et al., 2022).

Research into vibration therapy for chemotherapy-induced neuropathy is still in the early stages. Pilot studies of low-intensity vibration show that it may reduce symptoms and improve physical function in cancer survivors, but larger trials are needed to confirm these benefits (Krasnow et al., 2025; Sohrabzadeh et al., 2021).

The effects of vibration therapy can vary depending on how it is delivered. For example, some studies reported that pain relief lasted beyond the treatment session, while others did not find lasting nerve repair when nerve tissue was examined under a microscope. This shows that differences in vibration intensity, frequency, and session length may change the results (Kessler et al., 2020; De Oliveira Marques et al., 2021).

In clinical practice, vibration therapy is most helpful for people with diabetic, age-related, or length-dependent neuropathy who struggle with poor balance, reduced foot sensation, or chronic pain in the legs and feet. It is usually combined with other forms of therapy, such as balance training or strengthening exercises, to maximize results. Contraindications include recent blood clots, unstable heart disease, or recent fractures. Side effects are rare and mild, usually limited to brief muscle soreness, local discomfort, or dizziness.

Overall, vibration therapy appears to be a safe and promising treatment for improving balance, sensation, and pain in people with neuropathy. While early studies show good results, larger and more standardized clinical trials are still needed to fully understand its long-term benefits and the best treatment settings for different types of patients.

---

Nutritional Supplements for Nerve Health

Nutritional supplements play an important role in protecting nerve health and supporting recovery in people with neuropathy caused by diabetes, chemotherapy, or unknown reasons (Liu, 2020). Certain vitamins, fatty acids, and antioxidants have been studied for their ability to reduce nerve damage, improve blood flow, and ease symptoms.

One supplement that has received attention is benfotiamine, a form of vitamin B1. Unlike regular thiamine, benfotiamine can easily enter cells and helps the body process sugar in a safer way. By redirecting sugar into healthy pathways, it prevents harmful byproducts from building up and damaging nerves and blood vessels (Beltramo et al., 2008). While a two-year clinical trial using 300 mg per day did not show major changes in nerve function, shorter studies lasting 3 to 12 weeks found that higher doses, up to 600 mg daily, improved symptoms in people with diabetic neuropathy. These improvements included reduced pain and tingling, with few side effects (Fraser et al., 2012).

Another helpful nutrient is omega-3 fatty acids, especially EPA and DHA, which are found in fish oil. These healthy fats reduce inflammation and support the repair of nerve coverings (myelin). In a clinical trial with breast cancer patients, people who took 640 mg of omega-3s three times daily during chemotherapy were much less likely to develop neuropathy. About 70% of the omega-3 group avoided neuropathy, compared to only 40.7% in the placebo group (Ghoreishi et al., 2012). A review of several studies confirmed this protective effect, showing that omega-3 supplementation reduced the risk of chemotherapy-related neuropathy by almost half (Zhang et al., 2019). Other research has shown that omega-3s improve nerve structure in diabetes, and they are considered safe at daily doses of up to 3 grams of combined EPA and DHA.

Alpha-lipoic acid (ALA) is another important supplement. It is a strong antioxidant that also supports mitochondrial energy production. Clinical trials, such as SYDNEY-2 and NATHAN 1, found that taking 600 to 1,200 mg daily improved nerve blood flow and reduced symptoms of neuropathy over several months or years (Ziegler et al., 2006; Ziegler, 2023; Abdullah et al., 2024). Though generally safe, higher doses of ALA may cause mild stomach upset in some people.

The B-complex vitamins (thiamine, pyridoxine, folate, and cobalamin) are also critical for nerve health. They help nerves produce energy and maintain myelin, the protective covering around nerve fibers. However, too much vitamin B6 (pyridoxine), especially more than 50 mg daily, can actually cause nerve damage. For this reason, dosing should stay within safe, evidence-based ranges (Health Sciences Authority, 2023; Therapeutic Goods Administration, 2022).

Magnesium is another nutrient that helps nerves by stabilizing electrical signals and supporting healthy communication between nerve cells. While direct evidence in neuropathy is limited, correcting magnesium deficiency is widely recommended.

Supplements work best when combined with healthy habits such as controlling blood sugar, eating an anti-inflammatory diet rich in omega-3s, and staying active with balance and strength training. When combined, these strategies reduce oxidative stress, improve blood flow, and support nerve recovery. For example, benfotiamine helps process sugar safely, omega-3s lower inflammation, ALA protects against oxidative stress, and B vitamins support metabolism and repair.

Overall, the evidence supports using these supplements as part of a broader treatment plan for neuropathy. Their long-term success depends on early diagnosis, proper medical guidance, and integration with lifestyle and rehabilitation therapies. Doses should always be guided by a clinician to ensure both safety and effectiveness (Health Sciences Authority, 2023).

---

Chiropractic Care for Improved Movement and Body Mechanics in Neuropathy

Chiropractic care is a non-surgical treatment that focuses on improving joint movement, spinal alignment, and body mechanics. For people with neuropathy, these adjustments can reduce problems that often come with the condition, such as poor balance, changes in walking patterns, and extra pain from compensating movements. By restoring normal joint motion and posture, chiropractic adjustments may improve circulation, reduce stress on the body, and create a better environment for nerve healing.

When the spine or joints in the arms and legs do not move properly, the brain receives less accurate information about body position. This can negatively affect coordination and motor control. Chiropractors use hands-on adjustments and mobilization techniques to correct these problems. Improved joint function can reduce pain, allow for better movement patterns, and lower the risk of falls, which is a major concern for people with neuropathy (Pollock et al., 2022).

Although large clinical trials directly studying chiropractic care for neuropathy are limited, the approach is supported by research showing its positive effects on sensorimotor function. Case studies provide examples of success. In one case, a patient with severe burning and numbness in the feet completed a 12-week program that included chiropractic adjustments, infrared light therapy, electrical stimulation, and posture exercises. By the end of treatment, the patient reported much less pain, improved walking ability, and reduced reliance on medications (Chiropractic, 2025). Another report showed similar results when chiropractic care was combined with lifestyle coaching (Advantage Health Center, 2025).

Chiropractic care is often integrated with physical therapy, exercise, and rehabilitation. By correcting joint dysfunction, chiropractic adjustments can make it easier for patients to participate in balance training, strengthening, and other activities that are critical for stimulating nerves and restoring function. This collaborative approach supports better long-term outcomes (Comparative Efficacy of Chiropractic Adjustments in Peripheral Neuropathy Management, n.d.).

In summary, chiropractic care offers a supportive, drug-free method of improving movement and reducing secondary problems caused by neuropathy. While more research is needed to confirm its direct benefits for nerve health, current evidence and case reports suggest that it can play an important role when used alongside other therapies.

---

Vertebral Axial Decompression (VAX-D) Therapy in Neuropathy (Simplified, Paper Style)

Vertebral Axial Decompression, or VAX-D, is a non-surgical treatment that gently stretches the lower spine using a computer-controlled table. The goal is to lower the pressure inside the spinal discs, which can reduce nerve compression and improve symptoms. In one study, pressure inside a spinal disc dropped to below –100 mm Hg when VAX-D was applied, showing that the treatment can effectively decompress the discs (Ramos et al., 1994).

Research has tested VAX-D in people with chronic low back pain, many of whom also had leg symptoms related to nerve compression. In a large outcomes study of 778 patients, about 71% reported a successful result, which was defined as reducing pain to very low levels after at least 10 VAX-D sessions (Gose et al., 1998). Another randomized controlled trial compared VAX-D to TENS (a common nerve stimulation therapy) in patients with chronic back and leg pain. In that study, 68.4% of the VAX-D group achieved at least a 50% pain reduction, while none of the patients in the TENS group did (Naguszewski et al., 2001).

Other research supports its ability to reduce nerve compression. Using nerve tests, one study showed that patients with lower back and leg pain improved significantly, with 100% of participants reporting at least 50% symptom relief. On average, their pain decreased by 77% (Naguszewski et al., 2001).

However, there are also reports of risks. For example, one case described at the Mayo Clinic showed that repeated VAX-D sessions caused a spinal disc to enlarge suddenly, which worsened the patient’s pain and required surgery to correct (McMillin & Sherry, 2002). Because of these mixed results, insurance companies and policy groups remain cautious. While one trial did show VAX-D to be more effective than TENS, concerns about study design, limited generalizability, and safety risks have kept it from being widely accepted as a standard treatment (Aetna Clinical Policy Bulletins, 2025).

In summary, VAX-D shows promising results in reducing pain and nerve compression in some patients, but it also carries possible risks. More high-quality studies are needed to confirm how effective and safe it is before it can be recommended as a routine treatment for neuropathy.

---

Combined Therapy Approaches: Creating a Personalized Neuropathy Plan

Neuropathy is a complex condition, and no single treatment works best for everyone. Because of this, many doctors recommend combining therapies to address different parts of the problem at the same time. This approach, called multimodal therapy, often produces better results than using one method alone.

Neuropathy involves several processes, such as oxidative stress, inflammation, poor blood flow, high blood sugar, and nerve compression. Combining treatments can target these problems together. For example, one study of people with diabetic neuropathy found that using both strict blood sugar control and antioxidant supplements improved patient outcomes more than standard care alone. The percentage of patients who responded to treatment increased from 34% to nearly 39% after one year (Rotaru et al., 2020).

Other reviews also support this idea. Research has shown that combinations of drug treatments, such as gabapentin or pregabalin with anti-inflammatory medications, can reduce pain more effectively and cause fewer side effects than using each drug alone (Vorobeychik et al., 2011). While fewer trials have studied combinations of non-drug treatments, the reasoning is the same: therapies such as light therapy, shockwave therapy, electrical stimulation, vibration therapy, spinal decompression, and supplements all affect different parts of nerve health. Using them together can provide stronger, more lasting benefits.

Case studies highlight how this approach can work in real life. In one report, a patient with severe foot pain and numbness received a program that included chiropractic adjustments, infrared light therapy, electrical stimulation, supplements, and lifestyle coaching. The patient experienced major improvements, including reduced pain, better walking ability, and less reliance on medication (Chiropractic, 2025). While this is just one case, it shows how combining treatments can sometimes succeed when standard methods fail.

To create a personalized plan, doctors usually start with the patient’s main needs, such as controlling blood sugar, improving spinal alignment, or reducing compression. From there, other treatments can be added, such as light therapy, shockwave therapy, stimulation devices, and nutritional supplements. This layered approach allows care to be tailored to each individual, giving them the best chance for improvement.

Overall, evidence suggests that patients with neuropathy may benefit most from combined treatment plans that are guided by their specific symptoms, health conditions, and responses to therapy. Although more research is needed, the principle of targeting multiple causes of neuropathy at the same time offers both scientific credibility and practical hope for better outcomes.

---

Patient Success Stories: Real-World Recovery Journeys

Real-life experiences show how non-drug therapies can make a difference for people living with neuropathy. These stories highlight how treatments such as light therapy and chiropractic care have helped patients regain function and improve their quality of life.

One example is William, who had suffered from diabetic neuropathy for years. He experienced severe pain, tingling, numbness, and loss of feeling in his feet, which forced him to use a cane and disrupted his sleep. After starting infrared light therapy combined with hyperbaric oxygen treatments, William noticed less pain within two weeks. By the fifth week, he no longer needed his cane to move around his home and was able to climb stairs again. A clinical test showed that sensation had returned in almost all areas of his feet (Whitaker Wellness Institute).

Another story comes from Judy, who was told that her only option for relief was pain medication. Instead, she tried laser therapy at a chiropractic and nerve-focused clinic. After treatment, she regained feeling in her hands and feet and was able to return to daily activities that she had lost because of numbness (midwestspineandnerve.com).

Scott, who developed neuropathy after chemotherapy, also found relief through infrared light therapy. His pain decreased significantly, and he regained function in his hands and feet, allowing him to move more comfortably and return to his normal routines (midwestspineandnerve.com).

Lastly, Joan endured more than fifteen years of nightly neuropathic pain that made it almost impossible to sleep. After receiving infrared treatments three times per week for over two months, she finally began sleeping through the night. Her leg color returned to normal, and her pain was greatly reduced (midwestspineandnerve.com).

These stories show how non-surgical and non-drug treatments can help patients not only reduce pain but also regain mobility, independence, and quality of life. While these are individual cases, they provide encouraging examples of what is possible when therapies are matched to patient needs and followed consistently.

---

FAQs: Neuropathy Treatment Without Medications

Patients and families often have important questions about non-drug treatments for neuropathy. The following section addresses some of the most common concerns, based on current research.

One question is whether laser or light therapy is FDA-approved for neuropathy. At this time, low-level laser therapy (LLLT) and photobiomodulation are cleared by the FDA for improving circulation and reducing pain, but not specifically for reversing neuropathy. However, clinical trials show that these therapies can improve pain, sensation, and nerve function, which means doctors may use them “off-label” when there is evidence to support their benefit.

Another question patients ask is how long shockwave therapy takes to work. Studies suggest that extracorporeal shock wave therapy (ESWT) usually requires between one and five sessions, given weekly or every other week. Many patients begin to feel improvements in pain within four to six weeks, with early changes sometimes noticeable after the third session. Full results may take up to 12 to 16 weeks.

Patients also want to know if electrical stimulation therapies are effective. Research shows that TENS, PEMF, and H-Wave devices can reduce neuropathic pain. TENS often provides short-term relief, PEMF improves blood flow, and H-Wave may support circulation and longer-term function. Correct device settings and protocols are key for success.

Another common question is whether supplements can replace medication. Studies show that certain supplements, such as alpha-lipoic acid, omega-3 fatty acids, and benfotiamine, can improve symptoms and protect nerves. However, they are not a substitute for medications in severe or rapidly progressing cases. For example, alpha-lipoic acid has been shown to reduce neuropathy symptoms by 24–32%, and omega-3s may cut the risk of chemotherapy-induced neuropathy by half.

Safety is also a concern. Patients often ask if chiropractic care is safe for neuropathy. When performed by trained professionals, chiropractic adjustments and spinal decompression are generally safe and may improve circulation, mobility, and nerve function. However, chiropractic care may not be appropriate for patients with conditions like severe osteoporosis, spinal instability, or advanced spinal arthritis.

Patients may also wonder which therapies have the strongest evidence. Currently, alpha-lipoic acid and photobiomodulation have the most consistent support from randomized controlled trials. Other treatments such as shockwave therapy, PEMF, and vibration therapy are promising, but the studies are smaller and fewer in number. Many experts recommend using more than one therapy together for the best long-term results.

Finally, people ask whether neuropathy can be reversed. In some cases, yes. Early treatment with approaches like omega-3 supplementation and exercise may allow nerves to regenerate. However, when nerve damage has progressed too far, especially with long-term axonal loss, complete reversal is less likely. This is why early diagnosis and treatment are so important.

---

Conclusion

Neuropathy treatment has moved beyond only using medications that manage symptoms. While drugs such as gabapentin and pregabalin can reduce pain, they do not repair nerve damage and often cause side effects. Because of these limits, there is growing interest in safe, non-drug therapies that directly target the causes of nerve injury.

Research now shows that treatments such as photobiomodulation (light therapy), extracorporeal shockwave therapy, electrical stimulation, vibration therapy, and specific nutritional supplements can improve pain, restore sensation, and even improve nerve conduction. These results are especially encouraging for people with diabetic neuropathy or chemotherapy-induced neuropathy, who often have limited options. Chiropractic care and physical rehabilitation, including vertebral axial decompression when needed, may also support nerve health by improving circulation, balance, and overall body mechanics.

One of the most important lessons from current research is the value of early treatment. When neuropathy progresses too far, nerves may degenerate beyond repair. Starting care early, before too much nerve loss occurs, gives patients the best chance for recovery.

Another key point is the importance of integrating therapies. Using more than one treatment at the same time—such as combining supplements, light therapy, and physical rehabilitation—can target several aspects of neuropathy at once. This multimodal approach is often the most effective way to reduce pain, protect nerves, and restore function.

Overall, evidence supports an approach to neuropathy care that emphasizes protection, regeneration, and functional recovery. For patients, this means there is real hope. While complete reversal is not always possible, many people can experience meaningful improvements in quality of life, mobility, and independence when treatment is personalized, started early, and guided by evidence.

---

References

1. Abdullah, N., Tieppo Francio, V., Falowski, S., Ibrahim, Y., Malinowski, M., Budwany, R., ... & Pritzlaff, S. (2024). A Systematic Guideline by the ASPN Workgroup on the Evidence, Education and Treatment Algorithm for Painful Diabetic Neuropathy: SWEET.
2. Advantage Health Center. (2025, April 7). Case study: Relief from peripheral neuropathy with chiropractic care. Advantage Health. https://advantage-healthcenter.com/case-study-neuropathy-relief-eau-claire
3. Argenta, P. A., Ballman, K. V., Geller, M. A., Carson, L. F., Ghebre, R., Mullany, S. A., Teoh, D. G., Winterhoff, B. J., Rivard, C. L., & Erickson, B. K. (2016). The effect of photobiomodulation on chemotherapy-induced peripheral neuropathy: A randomized, sham-controlled clinical trial. Gynecologic Oncology, 144(1), 159–166. https://doi.org/10.1016/j.ygyno.2016.11.013
4. Baskozos, G., et al. (2023). Epidemiology of neuropathic pain: An analysis of prevalence. Pain Reports, 8(4), e1056. [Note: complete author list not specified; include as appropriate in final bibliography.
5. Beltramo, E., Berrone, E., Tarallo, S., & Porta, M. (2008). Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications. Acta diabetologica, 45(3), 131-141.
6. Blum, K., Chen, A. L., Chen, T. J., Prihoda, T. J., Schoolfield, J., DiNubile, N., Waite, R. L., Arcuri, V., Kerner, M., Braverman, E. R., Rhoades, P., & Tung, H. (2008). The H-Wave® device is an effective and safe non-pharmacological analgesic for chronic pain: a meta-analysis. Advances in Therapy, 25(7), 644–657. https://doi.org/10.1007/s12325-008-0073-3
7. Chen, Y., Chen, K., Yin, T., Huang, T., Yuen, C., Chung, S., Sung, P., Tong, M., Chen, C., Chang, H., Lin, K., Ko, S., & Yip, H. (2015, December 15). Extracorporeal shock wave therapy effectively prevented diabetic neuropathy. https://pmc.ncbi.nlm.nih.gov/articles/PMC4731656
8. Chiropractic, A. (2025, April 7). Case study: Treating peripheral neuropathy with Chiropractic care. Advantage Chiropractic. https://www.chiropractornewberlin.com/case-study-treating-neuropathy-with-chiropractic
9. Comparative efficacy of chiropractic adjustments in peripheral neuropathy management. (n.d.). https://www.backinactionbodyworks.com/blog/comparative-efficacy-of-chiropractic-adjustments-in-peripheral-neuropathy-management
10. De La Corte-Rodríguez, H., Román-Belmonte, J. M., Rodríguez-Damiani, B. A., Vázquez-Sasot, A., & Rodríguez-Merchán, E. C. (2023). Extracorporeal shock wave therapy for the treatment of musculoskeletal pain: A Narrative review. Healthcare, 11(21), 2830. https://doi.org/10.3390/healthcare11212830
11. De Oliveira Marques, C., Espindula, I. A., Darko, E. K. K., Bonetti, L. V., Sonza, A., Partata, W. A., Faccioni-Heuser, M. C., & Malysz, T. (2021). Whole-body vibration therapy does not improve the peripheral nerve regeneration in experimental model. https://pmc.ncbi.nlm.nih.gov/articles/PMC8020024
12. De Oliveira Rosso, M. P., Buchaim, D. V., Kawano, N., Furlanette, G., Pomini, K. T., & Buchaim, R. L. (2018). Photobiomodulation therapy (PBMT) in Peripheral Nerve Regeneration: A Systematic review. Bioengineering, 5(2), 44. https://doi.org/10.3390/bioengineering5020044
13. Dompe, C., Moncrieff, L., Matys, J., Grzech-Leśniak, K., Kocherova, I., Bryja, A., Bruska, M., Dominiak, M., Mozdziak, P., Skiba, T., Shibli, J., Volponi, A. A., Kempisty, B., & Dyszkiewicz-Konwińska, M. (2020). Photobiomodulation—Underlying mechanism and clinical applications. Journal of Clinical Medicine, 9(6), 1724. https://doi.org/10.3390/jcm9061724
14. Ebadi, S. A., Tabeie, F., Tavakoli, S., & Khalili, S. (2023). Effects of Photobiomodulation With Two Wavelengths of 630 and 810 nm on Diabetic Neuropathy. Journal of Lasers in Medical Sciences, 14, e22. https://doi.org/10.34172/jlms.2023.22
15. Effect of extracorporeal shockwaves on diabetic neuropathic foot. (2020). International Journal of Pharmaceutical Research, 12(04). https://doi.org/10.31838/ijpr/2020.sp2.554
16. Elafros, M. A., Kvalsund, M. P., & Callaghan, B. C. (2022). The global burden of polyneuropathy—In need of an accurate assessment. JAMA Neurology, 79(6), 537–538. https://doi.org/10.1001/jamaneurol.2022.0565
17. Foundation for Peripheral Neuropathy. (2025). The global burden of polyneuropathy. Retrieved from Foundation for Peripheral Neuropathy website.
18. Fraser, D. A., Diep, L. M., Hovden, I. A., Nilsen, K. B., Sveen, K. A., Seljeflot, I., & Hanssen, K. F. (2012). The effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trial. Diabetes Care, 35(5), 1095-1097.
19. Ghoreishi, Z., Esfahani, A., Djazayeri, A., Djalali, M., Golestan, B., Ayromlou, H., Hashemzade, S., Jafarabadi, M. A., Montazeri, V., Keshavarz, S. A., & Darabi, M. (2012). Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: A randomized double-blind placebo controlled trial. BMC Cancer, 12(1). https://doi.org/10.1186/1471-2407-12-355
20. Guo, J., Hai, H., & Ma, Y. (2022). Application of extracorporeal shock wave therapy in nervous system diseases: A review. Frontiers in Neurology, 13. https://doi.org/10.3389/fneur.2022.963849
21. Hammi C, Yeung B. Neuropathy [Internet]. StatPearls - NCBI Bookshelf. 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK542220/
22. Health Sciences Authority. (2023). High-dose vitamin B6 and risk of peripheral neuropathy. Retrieved from https://www.hsa.gov.sg/announcements/safety-alert/high-dose-vitamin-b6-and-risk-of-peripheral-neuropathy
23. Hicks, C. W., Wang, D., Windham, B. G., Matsushita, K., & Selvin, E. (2021). Prevalence of peripheral neuropathy defined by monofilament insensitivity in middle-aged and older adults in two US cohorts. Scientific Reports, 11(1), Article 19159. https://doi.org/10.1038/s41598-021-98565-w
24. International Society for Medical Shockwave Treatment. (2024, January 3). ISMST guidelines for extracorporeal shock wave therapy (ESWT). https://shockwavetherapy.org/wp-content/uploads/2024/01/ISMST-Guidelines-for-ESWT-_-engl-20240103.pdf
25. Jamal, A., Ahmad, I., Ahamed, N., Azharuddin, M., Alam, F., & Hussain, M. E. (2019). Whole body vibration showed beneficial effect on pain, balance measures and quality of life in painful diabetic peripheral neuropathy: a randomized controlled trial. Journal of Diabetes & Metabolic Disorders, 19(1), 61–69. https://doi.org/10.1007/s40200-019-00476-1
26. Jeong, D., Lee, J. H., Lee, G. B., Shin, K. H., Hwang, J., Jang, S. Y., Yoo, J., & Jang, W. Y. (2023). Application of extracorporeal shockwave therapy to improve microcirculation in diabetic foot ulcers: A prospective study. Medicine, 102(11), e33310. https://doi.org/10.1097/md.0000000000033310
27. Johnson, M. I., et al. (2022). A secondary analysis of the Meta-TENS study to improve pain management. Nih. 58(6), 803. https://doi.org/10.3390/jcm58060803
28. Johnson, M. I., Paley, C. A., Jones, G., Mulvey, M. R., & Wittkopf, P. G. (2022). Efficacy and safety of transcutaneous electrical nerve stimulation (TENS) for acute and chronic pain in adults: a systematic review and meta-analysis of 381 studies (the meta-TENS study). BMJ Open, 12(2), e051073. https://doi.org/10.1136/bmjopen-2021-051073
29. Johnson, M. I., Paley, C. A., Wittkopf, P. G., Mulvey, M. R., & Jones, G. (2022). Characterising the features of 381 clinical studies evaluating transcutaneous electrical nerve stimulation (TENS) for pain relief: A secondary analysis of the Meta-TENS Study to improve future research. Medicina, 58(6), 803. https://doi.org/10.3390/medicina58060803
30. Joshua, A. M., & Misri, Z. (2022). Peripheral nerve disorders. In Physiotherapy for Adult Neurological Conditions (pp. 621-729). Singapore: Springer Nature Singapore.
31. Kessler, N. J., Lockard, M. M., & Fischer, J. (2020). Whole body vibration improves symptoms of diabetic peripheral neuropathy. Journal of Bodywork and Movement Therapies, 24(2), 1–3. https://doi.org/10.1016/j.jbmt.2020.01.004
32. Korada, H. Y., Arora, E., Maiya, G. A., Rao, S., Hande, M., Shetty, S., Gundmi, S., Anche, P., & Amravadi, S. (2022). Effectiveness of photobiomodulation therapy on neuropathic pain, nerve conduction and plantar pressure distribution in diabetic peripheral neuropathy - a systematic review. Current Diabetes Reviews, 19(9). https://doi.org/10.2174/1573399818666220429085256
33. Kou, D., Chen, Q., Wang, Y., Xu, G., Lei, M., Tang, X., Ni, H., & Zhang, F. (2024). The application of extracorporeal shock wave therapy on stem cells therapy to treat various diseases. Stem Cell Research & Therapy, 15(1). https://doi.org/10.1186/s13287-024-03888-w
34. Krasnow, S. M., Rubin, C. T., Roeland, E. J., Horak, F. B., Stoyles, S. A., Dieckmann, N. F., Braun, K. N., & Winters-Stone, K. M. (2025). Low-Intensity vibration to reduce symptoms and improve physical functioning in cancer survivors with Chemotherapy-Induced peripheral neuropathy: a pilot randomized trial. JCO Oncology Practice. https://doi.org/10.1200/op-24-00961
35. Laforgia, M., Laface, C., Calabro, C., Ferraiuolo, S., Ungaro, V., Tricarico, D., ... & Ranieri, G. (2021). Peripheral neuropathy under oncologic therapies: a literature review on pathogenetic mechanisms. International journal of molecular sciences, 22(4), 1980.
36. Li L, Li T, Qu X, Sun G, Fu Q, Han G. Stress/cell death pathways, neuroinflammation and neuropathic pain. Immunological reviews. 2024 Jan;321(1):33-51.
37. Liu, Y. W., Liu, C. T., & Su, Y. L. (2020). A narrative review of complementary nutritional supplements for chemotherapy-induced peripheral neuropathy. Alternative Therapies in Health and Medicine, 26(4), 43-49.
38. Robinson, C. C., Barreto, R. P. G., & Della Méa Plentz, R. (2018, September 1). Effects of whole body vibration in individuals with diabetic peripheral neuropathy: a systematic review. https://pmc.ncbi.nlm.nih.gov/articles/PMC6146195
39. Rotaru, A., TÂrtea, E. A., & IancĂu, M. (2020). Classical therapies versus combined therapies in diabetic neuropathy. PubMed, 46(2), 123–128. https://doi.org/10.12865/chsj.46.02.04
40. Sabziparvar, M., Naghdi, S., Ansari, N. N., & Fateh, H. (2022). Implication of Local Plantar Vibration in Patients with Diabetic Neuropathy. Iranian Journal of Public Health. https://doi.org/10.18502/ijph.v51i8.10284
41. Saleh DO, Sedik AA. Novel drugs affecting diabetic peripheral neuropathy. Iranian Journal of Basic Medical Sciences. 2024;27(6):657.
42. Sohrabzadeh, E., Kalantari, K. K., Naimi, S. S., Daryabor, A., & Akbari, N. J. (2021). The immediate effect of a single whole-body vibration session on balance, skin sensation and pain in patients with type 2 diabetic neuropathy. Journal of Diabetes & Metabolic Disorders, 21(1), 43–49. https://doi.org/10.1007/s40200-021-00933-w
43. Tassone, E. E., Page, J. C., & Slepian, M. J. (2023). Assessing the effects of pulsed electromagnetic therapy on painful diabetic distal symmetric peripheral neuropathy: a Double-Blind randomized controlled trial. Journal of Diabetes Science and Technology. https://doi.org/10.1177/19322968231190413
44. Therapeutic Goods Administration. (2022). Health supplements containing vitamin B6 can cause peripheral neuropathy. Retrieved from https://www.tga.gov.au/news/safety-alerts/health-supplements-containing-vitamin-b6-can-cause-peripheral-neuropathy
45. Vance, C. G. T., Dailey, D. L., Chimenti, R. L., Van Gorp, B. J., Crofford, L. J., & Sluka, K. A. (2022). Using TENS for pain control: Update on the state of the evidence. Medicina, 58(10), 1332. https://doi.org/10.3390/medicina58101332
46. Vorobeychik, Y., Gordin, V., Mao, J., & Chen, L. (2011). Combination therapy for neuropathic pain. CNS Drugs, 25(12), 1023–1034. https://doi.org/10.2165/11596280-000000000-00000
47. Wang, Q., et al. (2024). The effects of pulsed electromagnetic field therapy on knee osteoarthritis: A randomized controlled trial. Frontiers in Medicine, 11, 1435277. https://doi.org/10.3389/fmed.2024.1435277
48. Williamson, T. K., Rodriguez, H. C., Gonzaba, A., Poddar, N., Norwood, S. M., & Gupta, A. (2021). H-Wave® Device stimulation: A critical review. Journal of Personalized Medicine, 11(11), 1134. https://doi.org/10.3390/jpm11111134
49. Wolfe, D., Rosenstein, B., & Fortin, M. (2024). The effect of EMS, IFC and TENS on patient-reported outcome measures for chronic low back pain: a systematic review and meta-analysis. Frontiers in Pain Research, 5. https://doi.org/10.3389/fpain.2024.1346694
50. Yang, L., Li, X., Li, S., Yang, J., & Meng, D. (2024). Effect of extracorporeal shock wave therapy on nerve conduction: a systematic review and meta-analysis. Frontiers in Neurology, 15. https://doi.org/10.3389/fneur.2024.1493692
51. Zhang, A. C., De Silva, M. E. H., MacIsaac, R. J., Roberts, L., Kamel, J., Craig, J. P., Busija, L., & Downie, L. E. (2019). Omega-3 polyunsaturated fatty acid oral supplements for improving peripheral nerve health: a systematic review and meta-analysis. Nutrition Reviews, 78(4), 323–341. https://doi.org/10.1093/nutrit/nuz054
52. Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, Munzel U, Yakhno N, Raz I, Novosadova M, Maus J. Oral treatment with α-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes care. 2006 Nov 1;29(11):2365-70.
53. Ziegler, D. (2023). Pathogenetic treatments for diabetic peripheral neuropathy. Diabetes Research and Clinical Practice, 206, 110764.
54. Ramos, G., & Martin, W. (1994). Effects of vertebral axial decompression on intradiscal pressure. Journal of Neurosurgery, 81(3), 350–353.
55. Gose, E. E. et al. (1998). Vertebral axial decompression treatment for pain associated with herniated or degenerated discs or facet syndrome: An outcome study. Neurological Research, 20(4).
56. Sherry E, Kitchener P, Smart R. A prospective randomized controlled study of VAX-D and TENS for the treatment of chronic low back pain. Neurol Res. 2001 Oct;23(7):780-4. doi: 10.1179/016164101101199180. PMID: 11680522.
57. Naguszewski, W. K. et al. (2001). Dermatomal somatosensory evoked potential demonstration of nerve root decompression after VAX-D therapy. Neurological Research, 23(7).
58. McMillin, D. S., & Sherry, E. (2002). Sudden progression of lumbar disk protrusion during vertebral axial decompression traction therapy. Mayo Clinic Proceedings.
59. Aetna. (2025). Vertebral Axial Decompression [Clinical Policy Bulletin].